Limited Submission Programs - Cancer Prevention and Research Institute of Texas (CPRIT): Shared Instrumentation Awards 2010 – 2011

Summary of Opportunity
Cancer Prevention and Research Institute of Texas (CPRIT): Shared Instrumentation Awards 2010 – 2011 [PDF]
OSP Deadline 12/01/10
Funding Agency Deadline 12/07/10
Funding or Award Criteria

Program Description: CPRIT has approved the issuance of Shared Instrumentation Awards with an anticipated Request for Application (RFA) release date on or before October 15, 2010.  The RFA will contain detailed information regarding eligibility, mechanism of support, receipt dates and application evaluation.

Shared Instrumentation Awards seek to support the acquisition of major research instrumentation that cannot be requested through other CPRIT programs and whose purchase can be justified on a shared-use basis to support the goals of the scientifically meritorious cancer research projects.  A wide variety of research instrumentation can be wholly or partially supported included, but not limited to, biomedical imaging systems, microscopes, cyclotrons, mass spectrometers, protein and DNA sequencers, flow cytometers, and cell sorters.  A major user group of investigators must be identified, each of whom should have supported research projects that make use of the requested instrumentation.  However, this requirement is not intended to exclude early-stage investigators who have not yet secured peer-reviewed grant support.  Alternatively, funding may be requested for instrumentation to develop state-of-the-art facilities with will directly support and impact cancer research programs at the institution and in the region. 

Only one instrument may be requested.  Collaborative applications are permitted.  The maximum duration of the award is 5 years.  The maximum amount that may be requested is $3 million for the first year (minimum $100,000) and up to $300,000 for each subsequent year.  Allowable expenses include the cost of the instrument, installation and/or necessary renovation expenses, and maintenance/service contracts; all of these costs and expenses must be prorated for direct use in cancer research and/or prevention efforts, and there must be an institutional commitment to provide further necessary funds.  In addition, applicants may request funds to support the use of the instrument by qualified cancer research investigators for relevant projects. 

Please see the solicitation for complete information.



Applicable Field(s)  
Number of Nominees Allowed ONE proposal
Required Internal Review Documents

Associate Deans or Designates must submit the following materials electronically to no later than 4:30 p.m. on Thursday, October 21, 2010 (NOTE: submissions directly from PIs will not be accepted):   

  1. Dean's or ORU Director's (or designates) Letter of Nomination with rankings and justification
  2. Two page maximum lay abstract describing the aims of/needs for of the proposed project. 

Each department may submit up to 2 internal applications. 

Nominee(s) Selected to Advance Dr. Maria Person, College of Pharmacy
Posting Date 10/05/10